about
Measles Virus Host Invasion and PathogenesisEarly target cells of measles virus after aerosol infection of non-human primatesPredominant infection of CD150+ lymphocytes and dendritic cells during measles virus infection of macaquesT-Cell tropism of simian varicella virus during primary infectionMeasles immune suppression: lessons from the macaque modelDrivers of airborne human-to-human pathogen transmissionThe synthetic bacterial lipopeptide Pam3CSK4 modulates respiratory syncytial virus infection independent of TLR activationDC-SIGN and CD150 have distinct roles in transmission of measles virus from dendritic cells to T-lymphocytes.Protective immunity in macaques vaccinated with a modified vaccinia virus Ankara-based measles virus vaccine in the presence of passively acquired antibodies.Relative contributions of measles virus hemagglutinin- and fusion protein-specific serum antibodies to virus neutralizationCombination of reverse transcriptase PCR analysis and immunoglobulin M detection on filter paper blood samples allows diagnostic and epidemiological studies of measlesMeasles virus suppresses RIG-I-like receptor activation in dendritic cells via DC-SIGN-mediated inhibition of PP1 phosphatasesInfection-enhancing lipopeptides do not improve intranasal immunization of cotton rats with a delta-G candidate live-attenuated human respiratory syncytial virus vaccineImmunization of macaques with formalin-inactivated respiratory syncytial virus (RSV) induces interleukin-13-associated hypersensitivity to subsequent RSV infectionPathological consequences of systemic measles virus infection.Long-term measles-induced immunomodulation increases overall childhood infectious disease mortality.A prominent role for DC-SIGN+ dendritic cells in initiation and dissemination of measles virus infection in non-human primates.Phocine distemper virus: current knowledge and future directions.Recombinant subgroup B human respiratory syncytial virus expressing enhanced green fluorescent protein efficiently replicates in primary human cells and is virulent in cotton rats.Live-attenuated measles virus vaccine targets dendritic cells and macrophages in muscle of nonhuman primates.Experimental vaccines against measles in a world of changing epidemiology.Vaccination against measles: a neverending story.Measles immune suppression: functional impairment or numbers game?Streptococcus pneumoniae Enhances Human Respiratory Syncytial Virus Infection In Vitro and In Vivo.Delineating morbillivirus entry, dissemination and airborne transmission by studying in vivo competition of multicolor canine distemper viruses in ferrets.Ferrets as a Novel Animal Model for Studying Human Respiratory Syncytial Virus Infections in Immunocompetent and Immunocompromised Hosts.Measles vaccination: new strategies and formulations.Rinderpest eradication: lessons for measles eradication?Evaluating measles vaccines: can we assess cellular immunity?Using the ferret model to study morbillivirus entry, spread, transmission and cross-species infection.Morbillivirus infections: an introduction.Modified Vaccinia Virus Ankara Preferentially Targets Antigen Presenting Cells In Vitro, Ex Vivo and In Vivo.Measles vaccination of nonhuman primates provides partial protection against infection with canine distemper virus.Measles vaccination effectiveness among children under 5 years of age in Kampala, Uganda.Paramyxovirus infections in ex vivo lung slice cultures of different host species.Specific CD8(+) T-lymphocytes control dissemination of measles virus.Measles virus infection of epithelial cells in the macaque upper respiratory tract is mediated by subepithelial immune cells.Depletion of measles virus glycoprotein-specific antibodies from human sera reveals genotype-specific neutralizing antibodies.Infection of cynomolgus macaques (Macaca fascicularis) and rhesus macaques (Macaca mulatta) with different wild-type measles viruses.In vivo tropism of attenuated and pathogenic measles virus expressing green fluorescent protein in macaques.
P50
Q26739968-F68BA35C-E733-4A1D-A7ED-1744769FF69DQ27312346-9F70B018-DA5A-4CD1-8A27-60B7EB13D114Q27319538-9F8D62FA-FE87-4B72-84DB-1ABE4BFD7A12Q27334810-17653DF4-2F2C-4BD6-8FE6-72BC5D7C5548Q27342799-6D4568E8-BCE9-49A4-ADF9-0732E7DB842EQ28078831-79A15236-5EA9-435F-A3A5-226F4ECA607EQ28749631-9AA9F8D3-6C86-4AE4-AC27-55422607879DQ33329098-834742F1-455C-4D2A-AC36-9814DD36F038Q33803714-0CC49D68-8C9D-4B4B-B550-142FA3412B1AQ33930445-C8D29A61-5176-4D35-ABB9-ACC4DD3E7959Q33970969-C05BC7E9-BD45-4400-BCA6-99EEB995C8FAQ34158123-E95DEE26-A046-4BDD-B570-7664A084753CQ34170117-8CF3145C-0370-43AE-A05C-4468204C6841Q34355131-89DB1872-2CD3-4CF5-AEE0-AF6FBD48F97EQ34442341-EEE6B3D6-4963-4D86-9A73-FEFF70FCA2B6Q34475557-E3EA10B7-971C-4083-A526-70547F2FE1E9Q34506876-E6563265-ED4E-44E3-B5C9-6071283A2E78Q34774818-40E87F57-71B2-408B-A8BC-A099E646C8C5Q35076761-EFB9C007-93CE-477E-A29A-915958D7BC53Q35115588-02F462C3-BB0E-4B31-B1C2-7DF36B736568Q35143277-F807F9F0-FD57-4A05-B65B-CE3722F0B5EFQ35193416-C415BAD7-97AC-4C38-97BF-22247F8156A6Q35529680-008958AB-61FD-4BD4-85DF-D37EE7E4BA07Q35603103-9FF0AB77-FEFB-4411-B8E9-8A893470A1BDQ36365747-8C8AA3CA-49B5-4D94-ADF2-C88B80F1CD0BQ37049972-8D932690-8DC1-4837-B486-2A1C4225988FQ37290110-ECBC7E9A-8E4A-44F7-A3BD-392CE5421691Q38019630-92C82D33-DD01-4DE1-AEB5-33A156629F62Q38036683-44B0E1E8-0BE7-4A5F-8483-CE900AC82EB7Q38187806-93D56C04-5D55-4FF7-BD93-0FA6D716B0DDQ38357057-B9932BC0-9FBB-4AC1-B865-4E564BBAC129Q38619090-E7D8EA1B-033B-4723-BF24-479B6C5EDB28Q38858493-DD90BDBB-6720-4196-9077-9564AEAB9CD3Q38879694-DF201BD6-BD33-449C-BDF4-D3217E690230Q39400521-26C3B292-5C6B-4B70-8D70-5890C65D9E12Q39768938-7DB5AF0F-F9A6-4CEE-828A-2F2ACFCE7344Q39789095-B6F28B0F-5354-4300-B48C-7BE3A3880486Q39807784-23A93468-20F0-45A3-8D01-3BC393C87BD6Q40205825-8AA847B3-3F8B-4CD6-8BF7-B289C0DD62B1Q40339180-CDDF1E14-6CA0-479D-995B-3BB18248F82E
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Rik L de Swart
@ast
Rik L de Swart
@en
Rik L de Swart
@es
Rik L de Swart
@nl
Rik L de Swart
@sl
type
label
Rik L de Swart
@ast
Rik L de Swart
@en
Rik L de Swart
@es
Rik L de Swart
@nl
Rik L de Swart
@sl
prefLabel
Rik L de Swart
@ast
Rik L de Swart
@en
Rik L de Swart
@es
Rik L de Swart
@nl
Rik L de Swart
@sl
P106
P1153
7003275675
P31
P496
0000-0003-3599-8969
P5008
P734
P735
P7449
PRS1278706